Aastrom Biosciences, Inc. (ASTM) Announces Pricing of Public Offering of Common Stock and Warrants
8/13/2013 9:17:46 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ANN ARBOR, Mich., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announced today that it has priced a public offering of 29,000,000 shares of its common stock, and warrants to purchase up to an aggregate of 29,000,000 shares of common stock, at a price to the public of $0.30 per share. The warrants have a per share exercise price of $0.37, are exercisable immediately, and expire five years from the date of issuance.
Help employers find you! Check out all the jobs and post your resume.
comments powered by